Advertisement

Chronic Nonbacterial Osteomyelitis

  • Liza McCann
  • Michael W. Beresford
  • Gabriele Hahn
  • Christian M. HedrichEmail author
Chapter

Abstract

Chronic nonbacterial osteomyelitis (CNO) is an autoinflammatory bone disorder that most commonly affects children and adolescents. While initially considered a benign disorder, we now know that CNO is a chronic and sometimes debilitating disease. The pathophysiology of CNO is incompletely understood. Imbalanced expression of pro- and anti-inflammatory cytokines contributes to osteoclast activation and bone inflammation. Animal models support these observations and suggest the involvement of alterations to the gut microbiome in disease pathology. Currently available treatment options inhibit inflammation and/or osteoclast activity and are efficacious in a large proportion of patients. However, prospective studies are missing, and some patients develop complications before “matching” treatment has been established. Here, we discuss disease presentation and outcomes, the current understanding of disease pathology, diagnostic approaches to CNO, available treatment options, and potential future directions.

Keywords

Chronic nonbacterial osteomyelitis CNO Chronic recurrent multifocal osteomyelitis CRMO Bone inflammation Inflammasome 

References

  1. 1.
    Ferguson PJ, El-Shanti HI. Autoinflammatory bone disorders. Curr Opin Rheumatol. 2007;19:492–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Ferguson PJ, Sandu M. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep. 2012;14:130–41.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Girschick HJ, Zimmer C, Klaus G, Darge K, Dick A, Morbach H. Chronic recurrent multifocal osteomyelitis: what is it and how should it be treated? Nat Clin Pract Rheumatol. 2007;3:733–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Hedrich CM, Hahn G, Girschick HJ, Morbach H. A clinical and pathomechanistic profile of chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis and challenges facing the field. Expert Rev Clin Immunol. 2013;9:845–54.PubMedCrossRefGoogle Scholar
  5. 5.
    Hedrich CM, Hofmann SR, Pablik J, Morbach H, Girschick HJ. Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J. 2013;11:47.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Hofmann SR, Schnabel A, Rosen-Wolff A, Morbach H, Girschick HJ, Hedrich CM. Chronic nonbacterial osteomyelitis: pathophysiological concepts and current treatment strategies. J Rheumatol. 2016;43:1956–64.PubMedCrossRefGoogle Scholar
  7. 7.
    Schnabel A, Range U, Hahn G, Siepmann T, Berner R, Hedrich CM. Unexpectedly high incidences of chronic non-bacterial as compared to bacterial osteomyelitis in children. Rheumatol Int. 2016;36:1737–45.PubMedCrossRefGoogle Scholar
  8. 8.
    Borzutzky A, Stern S, Reiff A, Zurakowski D, Steinberg EA, Dedeoglu F, et al. Pediatric chronic nonbacterial osteomyelitis. Pediatrics. 2012;130:e1190–e7.PubMedCrossRefGoogle Scholar
  9. 9.
    Girschick HJ, Raab P, Surbaum S, Trusen A, Kirschner S, Schneider P, et al. Chronic non-bacterial osteomyelitis in children. Ann Rheum Dis. 2005;64:279–85.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Ferguson PJL, Laxer RM. Autoinflammatory bone disorders. In: Petty L, Lindsley W, editors. Textbook of pediatric rheumatology. 7th ed. Philadelphia, PA: Elsevier; 2016. p. 627–41.Google Scholar
  11. 11.
    Giedion A, Holthusen W, Masel LF, Vischer D. Subacute and chronic “symmetrical” osteomyelitis. Ann Radiol (Paris). 1972;15:329–42.Google Scholar
  12. 12.
    Bjorksten B, Gustavson KH, Eriksson B, Lindholm A, Nordstrom S. Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris. J Pediatr. 1978;93:227–31.PubMedCrossRefGoogle Scholar
  13. 13.
    Probst FP, Bjorksten B, Gustavson KH. Radiological aspect of chronic recurrent multifocal osteomyelitis. Ann Radiol (Paris). 1978;21:115–25.Google Scholar
  14. 14.
    Hayem G, Bouchaud-Chabot A, Benali K, Roux S, Palazzo E, Silbermann-Hoffman O, et al. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum. 1999;29:159–71.PubMedCrossRefGoogle Scholar
  15. 15.
    Hofmann SR, Kapplusch F, Girschick HJ, Morbach H, Pablik J, Ferguson PJ, Hedrich CM. Chronic recurrent multi-focal osteomyelitis (CRMO): presentation, pathogenesis and treatment. Curr Osteoporos Rep. 2017;15(6):542–54.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Jansson AF, Grote V, Group ES. Nonbacterial osteitis in children: data of a German incidence surveillance study. Acta Paediatr. 2011;100:1150–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Wipff J, Costantino F, Lemelle I, Pajot C, Duquesne A, Lorrot M, et al. A large national cohort of French patients with chronic recurrent multifocal osteitis. Arthritis Rheumatol. 2015;67:1128–37.PubMedCrossRefGoogle Scholar
  18. 18.
    Huber AM, Lam PY, Duffy CM, Yeung RS, Ditchfield M, Laxer D, et al. Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up. J Pediatr. 2002;141:198–203.PubMedCrossRefGoogle Scholar
  19. 19.
    Vittecoq O, Said LA, Michot C, Mejjad O, Thomine JM, Mitrofanoff P, et al. Evolution of chronic recurrent multifocal osteitis toward spondyloarthropathy over the long term. Arthritis Rheum. 2000;43:109–19.PubMedCrossRefGoogle Scholar
  20. 20.
    Rohekar G, Inman RD. Conundrums in nosology: synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome and spondylarthritis. Arthritis Rheum. 2006;55:665–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Prose NS, Fahrner LJ, Miller CR, Layfield L. Pustular psoriasis with chronic recurrent multifocal osteomyelitis and spontaneous fractures. J Am Acad Dermatol. 1994;31:376–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Edwards TC, Stapleton FB, Bond MJ, Barrett FF. Sweet’s syndrome with multifocal sterile osteomyelitis. Am J Dis Child. 1986;140:817–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Majeed HA, Kalaawi M, Mohanty D, Teebi AS, Tunjekar MF, al-Gharbawy F, et al. Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with sweet syndrome in two siblings. J Pediatr. 1989;115:730–4.PubMedCrossRefGoogle Scholar
  24. 24.
    Arndt JH. Sweet’s syndrome and chronic recurrent multifocal osteomyelitis. Am J Dis Child. 1987;141:721.PubMedGoogle Scholar
  25. 25.
    Omidi CJ, Siegfried EC. Chronic recurrent multifocal osteomyelitis preceding pyoderma gangrenosum and occult ulcerative colitis in a pediatric patient. Pediatr Dermatol. 1998;15:435–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Koturoglu G, Vardar F, Ozkinay F, Kurugol Z, Akalin T, Ozkinay C. Pyoderma gangrenosum in a six-month-old boy. Turk J Pediatr. 2006;48:159–61.PubMedGoogle Scholar
  27. 27.
    Jansson A, Renner ED, Ramser J, Mayer A, Haban M, Meindl A, et al. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford). 2007;46:154–60.CrossRefGoogle Scholar
  28. 28.
    Schilling F, Marker-Hermann E. Chronic recurrent multifocal osteomyelitis in association with chronic inflammatory bowel disease: entheropathic CRMO. Z Rheumatol. 2003;62:527–38.PubMedCrossRefGoogle Scholar
  29. 29.
    Job-Deslandre C, Krebs S, Kahan A. Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases. Joint Bone Spine. 2001;68:245–51.PubMedCrossRefGoogle Scholar
  30. 30.
    Kim JE, Kolh EM, Kim DK. Takayasu’s arteritis presenting with focal periostitis affecting two limbs. Int J Cardiol. 1998;67:267–70.PubMedCrossRefGoogle Scholar
  31. 31.
    McConachie NS, Morley KD, Jones MC. Case report: periosteal new bone formation in Takayasu arteritis. Clin Radiol. 1995;50:578–80.PubMedCrossRefGoogle Scholar
  32. 32.
    Pelkonen P, Ryoppy S, Jaaskelainen J, Rapola J, Repo H, Kaitila I. Chronic osteomyelitislike disease with negative bacterial cultures. Am J Dis Child. 1988;142:1167–73.PubMedGoogle Scholar
  33. 33.
    Bousvaros A, Marcon M, Treem W, Waters P, Issenman R, Couper R, et al. Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children. Dig Dis Sci. 1999;44:2500–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Kerem E, Manson D, Laxer RM, Levison H, Reilly BJ. Pulmonary association in a case of chronic recurrent multifocal osteomyelitis. Pediatr Pulmonol. 1989;7:55–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Ravelli A, Marseglia GL, Viola S, Ruperto N, Martini A. Chronic recurrent multifocal osteomyelitis with unusual features. Acta Paediatr. 1995;84:222–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Assmann G, Kueck O, Kirchhoff T, Rosenthal H, Voswinkel J, Pfreundschuh M, et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Res Ther. 2009;11:R140.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Schilling F, Wagner AD. Azithromycin: an anti-inflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report. Z Rheumatol. 2000;59:352–3.PubMedCrossRefGoogle Scholar
  38. 38.
    Schultz C, Holterhus PM, Seidel A, Jonas S, Barthel M, Kruse K, et al. Chronic recurrent multifocal osteomyelitis in children. Pediatr Infect Dis J. 1999;18:1008–13.PubMedCrossRefGoogle Scholar
  39. 39.
    Bj0rksten B, Boquist L. Histopathological aspects of chronic recurrent multifocal osteomyelitis. J Bone Joint Surg Br. 1980;62:376–80.CrossRefGoogle Scholar
  40. 40.
    Jurik AG. Chronic recurrent multifocal osteomyelitis. Semin Musculoskelet Radiol. 2004;8:243–53.PubMedCrossRefGoogle Scholar
  41. 41.
    Girschick HJ, Huppertz HI, Harmsen D, Krauspe R, Muller-Hermelink HK, Papadopoulos T. Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbial testing. Hum Pathol. 1999;30:59–65.PubMedCrossRefGoogle Scholar
  42. 42.
    King SM, Laxer RM, Manson D, Gold R. Chronic recurrent multifocal osteomyelitis: a noninfectious inflammatory process. Pediatr Infect Dis J. 1987;6:907–11.PubMedCrossRefGoogle Scholar
  43. 43.
    Carr AJ, Cole WG, Roberton DM, Chow CW. Chronic multifocal osteomyelitis. J Bone Joint Surg Br. 1993;75:582–91.PubMedCrossRefGoogle Scholar
  44. 44.
    Hofmann SR, Kubasch AS, Ioannidis C, Rosen-Wolff A, Girschick HJ, Morbach H, et al. Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1beta expression and release. Clin Immunol. 2015;161:300–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Hofmann SR, Kubasch AS, Range U, Laass MW, Morbach H, Girschick HJ, et al. Serum biomarkers for the diagnosis and monitoring of chronic recurrent multifocal osteomyelitis (CRMO). Rheumatol Int. 2016;36:769–79.PubMedCrossRefGoogle Scholar
  46. 46.
    Hofmann SR, Morbach H, Schwarz T, Rosen-Wolff A, Girschick HJ, Hedrich CM. Attenuated TLR4/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression. Clin Immunol. 2012;145:69–76.PubMedCrossRefGoogle Scholar
  47. 47.
    Hofmann SR, Schwarz T, Moller JC, Morbach H, Schnabel A, Rosen-Wolff A, et al. Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin Immunol. 2011;141:317–27.PubMedCrossRefGoogle Scholar
  48. 48.
    Lucas M, Zhang X, Prasanna V, Mosser DM. ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus. J Immunol. 2005;175:469–77.PubMedCrossRefGoogle Scholar
  49. 49.
    Zhang X, Edwards JP, Mosser DM. Dynamic and transient remodeling of the macrophage IL-10 promoter during transcription. J Immunol. 2006;177:1282–8.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Greenhill CJ, Jones GW, Nowell MA, Newton Z, Harvey AK, Moideen AN, et al. Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction. Arthritis Res Ther. 2014;16:419.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Scianaro R, Insalaco A, Bracci Laudiero L, De Vito R, Pezzullo M, Teti A, et al. Deregulation of the IL-1beta axis in chronic recurrent multifocal osteomyelitis. Pediatr Rheumatol Online J. 2014;12:30.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Morbach H, Hedrich CM, Beer M, Girschick HJ. Autoinflammatory bone disorders. Clin Immunol. 2013;147:185–96.PubMedCrossRefGoogle Scholar
  53. 53.
    Nakashima T, Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol. 2009;29:555–67.PubMedCrossRefGoogle Scholar
  54. 54.
    Nakashima T, Takayanagi H. Osteoclasts and the immune system. J Bone Miner Metab. 2009;27:519–29.PubMedCrossRefGoogle Scholar
  55. 55.
    Aksentijevich I, Masters SL, Ferguson PJ, Dancey P, Frenkel J, van Royen-Kerkhoff A, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med. 2009;360:2426–37.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc. 1997;72:611–5.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Smith EJ, Allantaz F, Bennett L, Zhang D, Gao X, Wood G, et al. Clinical, molecular, and genetic characteristics of PAPA syndrome: a review. Curr Genomics. 2010;11:519–27.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Paller AS, Pachman L, Rich K, Esterly NB, Gonzalez-Crussi F. Pustulosis palmaris et plantaris: its association with chronic recurrent multifocal osteomyelitis. J Am Acad Dermatol. 1985;12:927–30.PubMedCrossRefGoogle Scholar
  59. 59.
    Festen JJ, Kuipers FC, Schaars AH. Multifocal recurrent periostitis responsive to colchicine. Scand J Rheumatol. 1985;14:8–14.PubMedCrossRefGoogle Scholar
  60. 60.
    Ben Becher S, Essaddam H, Nahali N, Ben Hamadi F, Mouelhi MH, Hammou A, et al. Recurrent multifocal periostosis in children. Report of a familial form. Ann Pediatr (Paris). 1991;38:345–9.Google Scholar
  61. 61.
    Ferguson PJ, Lokuta MA, El-Shanti HI, Muhle L, Bing X, Huttenlocher A. Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype. Arthritis Rheum. 2008;58:3264–9.PubMedCrossRefGoogle Scholar
  62. 62.
    Golla A, Jansson A, Ramser J, Hellebrand H, Zahn R, Meitinger T, et al. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur J Hum Genet. 2002;10:217–21.PubMedCrossRefGoogle Scholar
  63. 63.
    Beck C, Girschick HJ, Morbach H, Schwarz T, Yimam T, Frenkel J, et al. Mutation screening of the IL-1 receptor antagonist gene in chronic non-bacterial osteomyelitis of childhood and adolescence. Clin Exp Rheumatol. 2011;29:1040–3.PubMedGoogle Scholar
  64. 64.
    Hedrich CM, Bream JH. Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol Res. 2010;47:185–206.PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Hofmann SR, Rosen-Wolff A, Tsokos GC, Hedrich CM. Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury. Clin Immunol. 2012;143:116–27.PubMedCrossRefGoogle Scholar
  66. 66.
    Hamel J, Paul D, Gahr M, Hedrich CM. Pilot study: possible association of IL10 promoter polymorphisms with CRMO. Rheumatol Int. 2012;32:555–6.PubMedCrossRefGoogle Scholar
  67. 67.
    Hofmann SR, Roesen-Wolff A, Hahn G, Hedrich CM. Update: cytokine dysregulation in chronic nonbacterial osteomyelitis (CNO). Int J Rheumatol. 2012;2012:310206.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Cox ADB, Laxer R, Bing X, Finer A, Erives A, Mahajan V, Bassuk AG, Ferguson P. Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of sterile osteomyelitis [abstract]. Arthritis Rheumatol. 2016;68(suppl 10) http://acrabstracts.org/abstract/recessive-coding-and-regulatory-mutations-in-fblim1-underlie-the-pathogenesis-of-sterile-osteomyelitis/.
  69. 69.
    Cox AJ, Darbro BW, Laxer RM, Velez G, Bing X, Finer AL, Erives A, Mahajan VB, Bassuk AG, Ferguson PJ. Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of chronic recurrent multifocal osteomyelitis (CRMO). PLoS One. 2017;12(3):e0169687.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Chitu V, Nacu V, Charles JF, Henne WM, McMahon HT, Nandi S, et al. PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts. Blood. 2012;120:3126–35.PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Grosse J, Chitu V, Marquardt A, Hanke P, Schmittwolf C, Zeitlmann L, et al. Mutation of mouse Mayp/Pstpip2 causes a macrophage autoinflammatory disease. Blood. 2006;107:3350–8.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Liao HJ, Chyuan IT, Wu CS, Lin SW, Chen KH, Tsai HF, et al. Increased neutrophil infiltration, IL-1 production and a SAPHO syndrome-like phenotype in PSTPIP2-deficient mice. Rheumatology (Oxford). 2015;54:1317–26.CrossRefGoogle Scholar
  73. 73.
    Ahmed S, Bu W, Lee RT, Maurer-Stroh S, Goh WI. F-BAR domain proteins: families and function. Commun Integr Biol. 2010;3:116–21.PubMedPubMedCentralCrossRefGoogle Scholar
  74. 74.
    Tsujita K, Kondo A, Kurisu S, Hasegawa J, Itoh T, Takenawa T. Antagonistic regulation of F-BAR protein assemblies controls actin polymerization during podosome formation. J Cell Sci. 2013;126:2267–78.PubMedCrossRefGoogle Scholar
  75. 75.
    Cassel SL, Janczy JR, Bing X, Wilson SP, Olivier AK, Otero JE, et al. Inflammasome-independent IL-1beta mediates autoinflammatory disease in Pstpip2-deficient mice. Proc Natl Acad Sci U S A. 2014;111:1072–7.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Lukens JR, Gross JM, Calabrese C, Iwakura Y, Lamkanfi M, Vogel P, et al. Critical role for inflammasome-independent IL-1beta production in osteomyelitis. Proc Natl Acad Sci U S A. 2014;111:1066–71.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Netea MG, van de Veerdonk FL, van der Meer JW, Dinarello CA, Joosten LA. Inflammasome-independent regulation of IL-1-family cytokines. Annu Rev Immunol. 2015;33:49–77.PubMedCrossRefGoogle Scholar
  78. 78.
    Lukens JR, Gurung P, Vogel P, Johnson GR, Carter RA, McGoldrick DJ, et al. Dietary modulation of the microbiome affects autoinflammatory disease. Nature. 2014;516:246–9.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Ter Horst R, Jaeger M, Smeekens SP, Oosting M, Swertz MA, Li Y, et al. Host and environmental factors influencing individual human cytokine responses. Cell. 2016;167(1111–24):e13.Google Scholar
  80. 80.
    Jansson AF, Muller TH, Gliera L, Ankerst DP, Wintergerst U, Belohradsky BH, et al. Clinical score for nonbacterial osteitis in children and adults. Arthritis Rheum. 2009;60:1152–9.PubMedCrossRefGoogle Scholar
  81. 81.
    Roderick MR, Shah R, Rogers V, Finn A, Ramanan AV. Chronic recurrent multifocal osteomyelitis (CRMO) – advancing the diagnosis. Pediatr Rheumatol Online J. 2016;14:47.PubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    Duffy CM, Lam PY, Ditchfield M, Allen R, Graham HK. Chronic recurrent multifocal osteomyelitis: review of orthopaedic complications at maturity. J Pediatr Orthop. 2002;22:501–5.PubMedGoogle Scholar
  83. 83.
    Ferguson PJ, Sykelyk A, Figueredo R, Koropatnick J. Synergistic cytotoxicity against human tumor cell lines by oncolytic adenovirus dl1520 (ONYX-015) and melphalan. Tumori. 2016;102:31–9.PubMedCrossRefGoogle Scholar
  84. 84.
    Jurik AG, Egund N. MRI in chronic recurrent multifocal osteomyelitis. Skelet Radiol. 1997;26:230–8.CrossRefGoogle Scholar
  85. 85.
    Morbach H, Schneider P, Schwarz T, Hofmann C, Raab P, Neubauer H, et al. Comparison of magnetic resonance imaging and 99mTechnetium-labelled methylene diphosphonate bone scintigraphy in the initial assessment of chronic non-bacterial osteomyelitis of childhood and adolescents. Clin Exp Rheumatol. 2012;30:578–82.PubMedGoogle Scholar
  86. 86.
    Hofmann C, Wurm M, Schwarz T, Neubauer H, Beer M, Girschick H, et al. A standardized clinical and radiological follow-up of patients with chronic non-bacterial osteomyelitis treated with pamidronate. Clin Exp Rheumatol. 2014;32:604–9.PubMedGoogle Scholar
  87. 87.
    Khanna G, Sato TS, Ferguson P. Imaging of chronic recurrent multifocal osteomyelitis. Radiographics. 2009;29:1159–77.PubMedCrossRefGoogle Scholar
  88. 88.
    Jurik AG, Helmig O, Ternowitz T, Moller BN. Chronic recurrent multifocal osteomyelitis: a follow-up study. J Pediatr Orthop. 1988;8:49–58.PubMedCrossRefGoogle Scholar
  89. 89.
    Hofmann SR, Böttger F, Range U, Lück C, Morbach H, Girschick HJ, Suttorp M, Hedrich CM. Serum IL-6 and CCL11/eotaxin may be suitable biomarkers for the diagnosis of chronic nonbacterial osteomyelitis. Front Pediatr. 2017;5:256.PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Schnabel A, Range U, Hahn G, Berner R, Hedrich CM. Treatment response and long-term outcomes in children with chronic non-bacterial osteomyelitis (CNO). J Rheum. 2016;36(12):1737–45.Google Scholar
  91. 91.
    Girschick HJ, Krauspe R, Tschammler A, Huppertz HI. Chronic recurrent osteomyelitis with clavicular involvement in children: diagnostic value of different imaging techniques and therapy with non-steroidal anti-inflammatory drugs. Eur J Pediatr. 1998;157:28–33.PubMedCrossRefGoogle Scholar
  92. 92.
    Beck C, Morbach H, Beer M, Stenzel M, Tappe D, Gattenlohner S, et al. Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res Ther. 2010;12:R74.PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    Daniels MJ, Rivers-Auty J, Schilling T, Spencer NG, Watremez W, Fasolino V, et al. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer’s disease in rodent models. Nat Commun. 2016;7:12504.PubMedPubMedCentralCrossRefGoogle Scholar
  94. 94.
    Carpenter E, Jackson MA, Friesen CA, Scarbrough M, Roberts CC. Crohn’s-associated chronic recurrent multifocal osteomyelitis responsive to infliximab. J Pediatr. 2004;144:541–4.PubMedCrossRefGoogle Scholar
  95. 95.
    Twilt M, Laxer RM. Clinical care of children with sterile bone inflammation. Curr Opin Rheumatol. 2011;23:424–31.PubMedCrossRefGoogle Scholar
  96. 96.
    Hospach T, Langendoerfer M, von KT MJ, Dannecker GE. Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. Eur J Pediatr. 2010;169:1105–11.PubMedCrossRefGoogle Scholar
  97. 97.
    Tlougan BE, Podjasek JO, O'Haver J, Cordova KB, Nguyen XH, Tee R, et al. Chronic recurrent multifocal osteomyelitis (CRMO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with associated neutrophilic dermatoses: a report of seven cases and review of the literature. Pediatr Dermatol. 2009;26:497–505.PubMedCrossRefGoogle Scholar
  98. 98.
    Miettunen PM, Wei X, Kaura D, Reslan WA, Aguirre AN, Kellner JD. Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J. 2009;7:2.PubMedPubMedCentralCrossRefGoogle Scholar
  99. 99.
    Zhao Y, Chauvin NA, Jaramillo D, Burnham JM. Aggressive therapy reduces disease activity without skeletal damage progression in chronic nonbacterial osteomyelitis. J Rheumatol. 2015;42:1245–51.PubMedCrossRefGoogle Scholar
  100. 100.
    Pardeo M, Pires Marafon D, Messia V, Garganese MC, De Benedetti F, Insalaco A. Anakinra in a cohort of children with chronic nonbacterial osteomyelitis. J Rheumatol. 2017;44:1231–8.PubMedCrossRefGoogle Scholar
  101. 101.
    Zhao Y, Wu EY, Oliver MS, Cooper AM, Basiaga ML, Vora SS, Lee TC, Fox E, Amarilyo G, Stern SM, Dvergsten JA, Haines KA, Rouster-Stevens KA, Onel KB, Cherian J, Hausmann JS, Miettunen P, Cellucci T, Nuruzzaman F, Taneja A, Barron KS, Hollander MC, Lapidus SK, Li SC, Ozen S, Girschick H, Laxer RM, Dedeoglu F, Hedrich CM, Ferguson PJ, The CRMO study group and the CARRA SVARD subcommittee. Consensus treatment plans for chronic nonbacterial osteomyelitis refractory to nonsteroidal anti inflammatory drugs and/or with active spinal lesions. In preparation; 2017.Google Scholar
  102. 102.
    Zhao Y, Wu EY, Oliver MS, Cooper AM, Basiaga ML, Vora SS, et al. Consensus treatment plans for chronic nonbacterial osteomyelitis refractory to nonsteroidal anti-inflammatory drugs and/or with active spinal lesions. Arthritis Care Res (Hoboken). 2018;70(8):1228–37.  https://doi.org/10.1002/acr.23462. Epub 2018 Jul 12. PMID: 29112802. [Epub ahead to print].CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Liza McCann
    • 1
    • 2
  • Michael W. Beresford
    • 1
    • 2
  • Gabriele Hahn
    • 3
  • Christian M. Hedrich
    • 1
    • 2
    Email author
  1. 1.Department of Women’s & Children’s HealthInstitute of Translational Medicine, University of LiverpoolLiverpoolUK
  2. 2.Department of Paediatric RheumatologyAlder Hey Children’s NHS Foundation Trust HospitalLiverpoolUK
  3. 3.Institute of Radiology, Faculty of Medicine Carl Gustav CarusUniversity of Technology DresdenDresdenGermany

Personalised recommendations